Brand Names: Tritace, Altace
Generic Name: Ramipril
Manufacturer: Aventis
 

Ramipril Indications
Ramiprilat, the active metabolite of ramipril, is a potenet and long-acting angiotensin converting enzyme (ACE) inhibitor Administration of Tritace results in a vasodilatation and, especially in hypertensive patients, in a reduction of blood pressure. The blood-pressure-lowering effect of a single dose occurs within 1-2 hours after intake, reaching its peak within 3-6 hours, and usually lasts 24 hours.

Tritace is also effective in the treatment of congestive heart failure. Further, in patients demonstrating clinical signs of congestive heart failure after an acute muocordial infarction, Tritace has been shown to decrease the mortality risk (including the risk of sudden death, of progresion to severe/resistant heart failure and of failure-related hospitalisation).